June 23, 2014 — Researchers have announced the results of a study that used contrast ultrasound molecular imaging (CMI) to examine a relatively new role for platelets at early to mid stages of atherosclerosis. Atherosclerosis, or hardening of the arteries due to plaque buildup, can lead to many serious health problems, including stroke and coronary heart disease.

“It is well known that platelets, which are a constituent of blood clots, play a role in forming large clots that occlude arteries in stroke and heart attack. Our study opens up a whole new perspective on how platelets play a role in provoking the earlier initiation and growth of atherosclerotic plaques,” said primary investigator Chi Young Shim, M.D., Ph.D. Shim is a postdoctoral researcher at Oregon Health & Science University in Portland, Ore.; she and her colleagues used molecular imaging with “smart” targeted microbubbles to detect the sticking of platelets to the vessel wall at various stages of atherosclerosis. 

Jonathan Lindner, M.D., senior investigator of the study, added, “It has been suspected that platelet adhesion to the inner lining of blood vessels, even temporarily, can result in the deposition of harmful chemicals that can promote plaque growth and instability from the platelet to the vessel wall. This study is the first to definitively show that this process happens in the early stage of the disease. We also used smart microbubbles to evaluate the mechanism that causes them to stick, which involves the oxidative stress and the abnormal growth of sticky molecules (Von Willebrand factor) on the plaque surface. These results are important because they now give us a possible therapeutic target for new very potent anti-oxidant therapy.”

Researchers on the study, “Platelet Attachment to Vascular Endothelium Occurs in Both Early and Late-Stage Atherosclerosis Secondary to Dysregulation of Von Willebrand Factor: Evaluation by Contrast Ultrasound Molecular Imaging,” included Shim, Linder, Ya Ni Liu, Tami Atkinson, Mackenzie Treible, Aris Xie, Yue Qi, Ted Foster and Todd Belcik from Oregon Health & Science University; Zaverio Ruggeri from Scripps Research Institute in La Jolla, Calif.; and Jose Lopez from University of Washington in Portland.

The results were presented at the 25th annual scientific sessions of the American Society of Echocardiography (ASE) in Portland.

For more information: www.asecho.org


Related Content

News | FDA

July 8, 2025 — Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed ...

Time July 08, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Breast Imaging

Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...

Time March 03, 2025
arrow
News | Focused Ultrasound Therapy

Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been ...

Time January 08, 2025
arrow
Subscribe Now